Manipal Health Enterprises (BOM:544847) Stock Based Compensation: ₹330 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544847 Manipal Health Enterprises Ltd BOM:544847
13 GF Score
Price ₹771.85
! 1 Warning Sign
View Full Analysis

What is Manipal Health Enterprises Stock Based Compensation?

Manipal Health Enterprises BOM:544847 -3.22% 13 Stock Based Compensation is ₹330 Mil as of Mar. 2026. GuruFocus rates BOM:544847 with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Manipal Health Enterprises's Stock Based Compensation for the six months ended in Mar. 2026 was ₹330 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was ₹330 Mil.

Manipal Health Enterprises Stock Based Compensation Related Terms

Manipal Health Enterprises Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Manipal Health Enterprises's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Manipal Health Enterprises Stock Based Compensation Chart

Manipal Health Enterprises Annual Data
Trend Mar24 Mar25 Mar26
Stock Based Compensation
135.26 388.28 329.74

Manipal Health Enterprises Semi-Annual Data
Mar24 Mar25 Mar26
Stock Based Compensation 135.26 388.28 329.74
BOM:544847
13GF Score
Manipal Health Enterprises Ltd BOM:544847
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Manipal Health Enterprises Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was ₹330 Mil.

What does a Stock Based Compensation of ₹330 Mil mean?
Manipal Health Enterprises (BOM:544847) has a Stock Based Compensation of ₹330 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Manipal Health Enterprises and its competitors.
Is Manipal Health Enterprises' Stock Based Compensation too high?
Manipal Health Enterprises' current Stock Based Compensation is ₹330 Mil. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' Stock Based Compensation compare to HCA and THC?
Manipal Health Enterprises' Stock Based Compensation of ₹330 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Manipal Health Enterprises and its competitors. Manipal Health Enterprises's current Stock Based Compensation is ₹330 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (BOM:544847) has a current Stock Based Compensation of ₹330 Mil. The current Stock Based Compensation is ₹330 Mil. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Manipal Health Enterprises (BOM:544847), the current Stock Based Compensation is ₹330 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Manipal Health Enterprises Business Description

Other Exchanges MANIPALHOS:India
Address HAL Airport Road, Rustom Bagh road, The Annexe, no. 98/2, Bengaluru, KA, IND, 560 017
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score

Get the complete analysis for BOM:544847

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹771.85
Price